Peter Timmerman, Head of Peptide Science at Biosynth, joined the group following the acquisition of Pepscan in 2022, where he had served as chief scientific officer since 2001.
He drives advancements in protein mimicry for peptide drug discovery programs. Timmerman is the inventor of CLIPS technology and previously held a chair as a Professor at the University of Amsterdam. He obtained his Chemistry degree from Vrije Universiteit (Amsterdam) and earned his PhD cum laude from the University of Twente. Timmerman has co-authored over 80 scientific papers and holds more than 10 patents.